AI Will Not Close the Readiness Gap in Clinical Trials. It Will Expose It.
The clinical trials industry is moving fast on AI. The assumption underneath most of that momentum, that better tooling will narrow the performance gap between site teams, deserves a direct challenge. AI does not close the readiness divide. Applied to the work of running a trial, it is more likely to widen it.
